APA (7th ed.) Citation

Perret, R., Escuriol, J., Velasco, V., Mayeur, L., Soubeyran, I., Delfour, C., . . . Le Loarer, F. (2020). NFATc2-rearranged sarcomas: Clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker. Modern pathology, 33(10), 1930-1944. https://doi.org/10.1038/s41379-020-0542-z

Chicago Style (17th ed.) Citation

Perret, Raul, et al. "NFATc2-rearranged Sarcomas: Clinicopathologic, Molecular, and Cytogenetic Study of 7 Cases with Evidence of AGGRECAN as a Novel Diagnostic Marker." Modern Pathology 33, no. 10 (2020): 1930-1944. https://doi.org/10.1038/s41379-020-0542-z.

MLA (9th ed.) Citation

Perret, Raul, et al. "NFATc2-rearranged Sarcomas: Clinicopathologic, Molecular, and Cytogenetic Study of 7 Cases with Evidence of AGGRECAN as a Novel Diagnostic Marker." Modern Pathology, vol. 33, no. 10, 2020, pp. 1930-1944, https://doi.org/10.1038/s41379-020-0542-z.